Not provided
Not provided
| ID | Type | Description | Link |
|---|---|---|---|
| 2017-A02742-51 | Other Identifier | ID-RCB |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| URC-CIC Paris Descartes Necker Cochin | OTHER |
Not provided
Not provided
Not provided
Not provided
The purpose of the study is to identify biomarkers allowing the distinction between invasive and non-invasive strains of Staphylococcus epidermidis. This distinction is important to determine if the patient is infected and, as a consequence, if an antibiotic treatment is required.
In the hospital, a large proportion of bacteraemia and implantable medical device infections are caused by Staphylococcus epidermidis. This microorganism is the most abundant on human skin and all patients are carriers. Its remarkable ability to form biofilms on most materials explains that catheter-related infections are by far the most common.
S. epidermidis infections are difficult to treat because most strains are multi-resistant and antibiotics are less effective in the presence of biofilms.
In addition, S. epidermidis poses a major diagnostic problem because it is also the first source of contamination of blood culture sample and intraoperative samples (in case of suspected infection of orthopedic material in particular). Thus, when a sample is positive for S. epidermidis, there is less than a 25% chance that it reflects true bacteremia in the patient and 30% of patients would inappropriately receive vancomycin following contaminated blood cultures. Differentiating a contamination of a blood or intraoperative sample from true S. epidermidis infection is therefore crucial for patient management because unnecessary antibiotic therapy is potentially responsible for the emergence of resistant strains, toxicity and additional costs.
The objective of this study is to identify the genetic markers that make it possible to differentiate the strains causing infections from the strains causing contamination by comparing their genomes using high throughput sequencing.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| S. epidermidis Infection (CASE) | Patients with confirmed infection at S. epidermidis |
| |
| S. epidermidis Contamination (CONTROL) | Patients with confirmed contamination at S. epidermidis |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| high-throughput sequencing | Diagnostic Test | technique of high-throughput sequencing of the markers present in the genome of the S. epidermidis strains responsible for infection in order to help to discriminate the true infections of the contaminations |
| Measure | Description | Time Frame |
|---|---|---|
| genetic markers of S. epidermidis | to identify genetic markers associated with a significant risk of invasive S. epidermidis infections | at the time of the positive sampling of S. epidermidis |
| Measure | Description | Time Frame |
|---|---|---|
| Correlation of the genotype with the characteristics of the infections | identification of genetic markers specifically associated with a type of infection (catheter-related bacteremia in newborns, catheter-related bacteremia in patients 28 days or older, infections of orthopedic equipment or infections of cardiac equipment) | at the time of the positive sampling of S. epidermidis |
Not provided
Inclusion Criteria:
CASE Inclusion Criteria:
Population 1: nosocomial bacteraemia associated with intravascular devices
Sub-Population 1A:
3a) Aged less than 28 days (New-born)
Sub-population 1B:
3b) Aged 28 days or more
Population 2: nosocomial infections of implanted material
CONTROL Inclusion Criteria:
Population 1: carrier of intravascular devices
Sub-Population 1A:
3a) Aged less than 28 days (Newborn)
Sub-population 1B:
3b) Aged 28 days or more
Population 2: carrier of implanted material
Exclusion Criteria:
CASE Exclusion Criteria Population 1: nosocomial bacteremia associated with intravascular devices
Population 2: nosocomial infections of implanted material
CONTROL Exclusion Criteria
Populations 1 and 2:
Opposition of the patient or the holders of parental authority (minor patients)
Not provided
Not provided
Not provided
Not provided
Population 1 (bacteraemia related to intravascular devices) : patients hospitalized for at least 48 hours including new-borns
Population 2 (infections of materials) : patients carrying medical devices implanted following an act of surgery (orthopedic, cardiac or neurosurgery)
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Anne JAMET, MD | Assistance Public Hôpitaux de Paris (APHP) | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Hôpital Necker Enfants Malades | Paris | Île-de-France Region | 75015 | France |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 33328176 | Result | Jamet A, Guglielmini J, Brancotte B, Coureuil M, Euphrasie D, Meyer J, Roux J, Barnier JP, Bille E, Ferroni A, Magny JF, Bole-Feysot C, Charbit A, Nassif X, Brisse S. High-Resolution Typing of Staphylococcus epidermidis Based on Core Genome Multilocus Sequence Typing To Investigate the Hospital Spread of Multidrug-Resistant Clones. J Clin Microbiol. 2021 Feb 18;59(3):e02454-20. doi: 10.1128/JCM.02454-20. Print 2021 Feb 18. |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Intra-hospital cross-transmission detection | The comparison of the strains will be based on the study of the variations in the part of the genome that is common to all the strains to detect possible transfers between patients | at the time of the positive sampling of S. Epidermidis |